Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...
Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Attribution researches the influence of climate change on local weather and impacts. We issues alerts in many instances when the Climate Shift Index identifies a notable extreme weather event around ...
Monitoring performance and maintenance of PRVs using acoustic transmitters minimizes product loss and emissions ...
Attribution researches the influence of climate change on local weather and impacts. We issues alerts in many instances when the Climate Shift Index identifies a notable extreme weather event around ...
Cold-related illnesses (CRIs) are preventable yet often deadly. Using twenty-five years of data from the National Inpatient ...
In 2026, the intelligence community (IC) is facing an unprecedented challenge, and tactical-level intelligence ...
A May 9–12 program in Arezzo, Italy supports goldsmiths on market challenges and innovation.
3don MSN
Zevra outlines celiprolol interim analysis trigger at 28 events while expanding MIPLYFFA access
Q1 2026 Management View "We made substantial progress in establishing MIPLYFFA as a foundational treatment for Niemann-Pick disease type C or NPC in the U.S. by delivering meaningful clinical impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results